C17h25no5

Introduction

C17H25NO5 denotes a molecular formula that can represent a variety of organic compounds, including pharmaceuticals, natural products, and synthetic intermediates. The formula specifies that a molecule contains seventeen carbon atoms, twenty‑five hydrogen atoms, one nitrogen atom, and five oxygen atoms. This composition allows for a range of functional groups such as amines, carboxylic acids, esters, lactones, ketones, and alcohols, making it a versatile scaffold in medicinal chemistry and industrial synthesis. The following article presents a detailed examination of the structural possibilities, representative compounds, physical and chemical characteristics, synthetic routes, analytical identification, biological activity, regulatory considerations, environmental impact, and practical applications associated with this molecular formula.

Structural Overview

General Formula Analysis

The empirical formula C17H25NO5 indicates a degree of unsaturation calculated as follows: DU = (2C + 2 + N - H - X)/2, where X represents halogens. Substituting the values gives DU = (2*17 + 2 + 1 - 25)/2 = (34 + 2 + 1 - 25)/2 = 12/2 = 6. Thus, molecules with this formula typically contain six rings and/or double bonds. This high degree of unsaturation permits the formation of aromatic rings, heterocycles, and conjugated systems, all of which contribute to distinct physicochemical and biological properties.

Functional Group Distribution

Typical functional groups that can appear in C17H25NO5 compounds include:

Primary, secondary, or tertiary amines (–NH2, –NRH, –NR2)
Carboxylic acids (–COOH)
Esters (–COOR)
Lactones (cyclic esters)
Alkoxy groups (–OR)
Keto groups (C=O)
Aromatic rings (phenyl, heteroaromatic)
Aliphatic chains or cycloalkanes

The presence of these groups allows for diverse reactivity patterns, including nucleophilic addition, electrophilic substitution, and radical processes. The nitrogen atom can be protonated or deprotonated depending on the pH, influencing solubility and membrane permeability.

Isomeric Possibilities

Constitutional Isomers

Constitutional, or structural, isomers arise from different arrangements of the atoms that preserve the overall formula. For C17H25NO5, possible frameworks include:

A benzene ring bearing an amide and two ester substituents
A pyridine ring fused to a lactone moiety
An open-chain tertiary amine with a long aliphatic side chain and multiple ester groups
Multiple cyclic structures such as bicyclic lactams
A polycyclic skeleton containing both heteroatoms and multiple rings

Each arrangement gives rise to unique physicochemical properties such as melting point, solubility, and reactivity.

Stereoisomers

Chirality is common in compounds with this formula due to the presence of sp3 carbons adjacent to heteroatoms. Stereoisomerism can be introduced through:

Asymmetric carbon atoms in side chains
Chiral centers in lactone or lactam rings
E/Z isomerism across double bonds in conjugated systems

Enantiomers can exhibit markedly different pharmacodynamics and pharmacokinetics, making stereochemistry a critical factor in drug design.

Representative Compounds

Pharmaceutical Examples

Several marketed drugs share the molecular formula C17H25NO5, including:

Carvedilol analogs, known for β‑blocker activity
Some serotonin‑reuptake inhibitors featuring a tricyclic core
Inhibitors of certain kinases that incorporate a quinazoline scaffold with ester substituents

Although the exact structures vary, these compounds generally contain a core aromatic or heteroaromatic system, an amine moiety, and one or more ester or lactone functionalities.

Natural Products

Natural products such as alkaloids, terpenoids, and glycosides can also fall within this formula. Examples include:

Alkaloids with a phenanthridine backbone and methoxy groups
Terpenoid derivatives containing lactone rings and nitrogenous side chains
Polyketide antibiotics with a combination of aromatic and aliphatic regions

These natural compounds often possess complex stereochemistry and serve as templates for synthetic analogs.

Industrial Reagents

In industrial chemistry, C17H25NO5 compounds are utilized as building blocks or intermediates in the synthesis of polymers, agrochemicals, and specialty materials. Their functional groups facilitate cross‑linking reactions, polymerization, or further derivatization.

Physical and Chemical Properties

Molecular Weight and Formula Mass

The exact molecular mass depends on the isotopic composition of the atoms involved. Using standard atomic weights:

Carbon: 12.011 × 17 = 204.187
Hydrogen: 1.008 × 25 = 25.200
Nitrogen: 14.007 × 1 = 14.007
Oxygen: 15.999 × 5 = 79.995

Summing these values yields a nominal molecular weight of approximately 323.389 g·mol⁻¹.

Melting and Boiling Points

Melting points for compounds with this formula typically range from –10 °C to 220 °C, depending on crystal packing and hydrogen‑bonding networks. Boiling points often lie between 350 °C and 450 °C under reduced pressure, reflecting the presence of multiple carbonyl and ether linkages that elevate thermal stability.

Solubility

Solubility in aqueous media varies with pH and the presence of ionizable groups. Compounds bearing free carboxylic acids may be more soluble in alkaline solutions, whereas amide or ester‑containing molecules may show limited water solubility but dissolve readily in organic solvents such as ethanol, acetone, and dimethyl sulfoxide. The lipophilic character is influenced by the ratio of aromatic to aliphatic carbons and the extent of hydrogen‑bonding sites.

Spectral Data

Typical nuclear magnetic resonance (NMR) signatures include aromatic proton resonances between 6.5 and 8.5 ppm, methylene and methine signals in the range 1.0–3.5 ppm, and exchangeable protons (–NH, –OH) that appear as broad signals. Infrared spectroscopy reveals carbonyl stretches near 1750–1700 cm⁻¹ for esters, 1650–1600 cm⁻¹ for amides, and –OH stretches around 3300–3500 cm⁻¹. Mass spectra often display a molecular ion [M+H]⁺ at m/z ≈ 324 and fragment ions indicative of cleavage of ester or amide bonds.

Synthetic Strategies

Retrosynthetic Analysis

Designing synthetic routes for C17H25NO5 compounds involves identifying key building blocks that deliver the desired functional groups. Common retrosynthetic disconnections include:

Breaking an ester bond to expose a carboxylic acid and an alcohol
Disassembling a lactone to obtain a β‑hydroxy acid precursor
Opening a heterocyclic ring to expose a nitrogen atom for substitution
Dividing an aromatic system into smaller fragments that can be coupled via Friedel–Crafts alkylation or Suzuki coupling

These strategies often lead to convergent synthesis, where two or more complex fragments are joined in a final coupling step.

Key Reactions

Several reactions are frequently employed to assemble C17H25NO5 structures:

Condensation of a carboxylic acid with a primary alcohol in the presence of acid catalysts (e.g., DCC, DMAP) to form esters.
Formation of lactones via intramolecular esterification of β‑hydroxy acids under acid or base catalysis.
Amide bond formation through activation of carboxylic acids with carbodiimides or coupling reagents (e.g., HATU, EDC).
Reduction of nitro groups to amines using catalytic hydrogenation or metal‑hydride reagents (e.g., LiAlH4).
Nucleophilic substitution of halides with amines or phenols to introduce nitrogen or oxygen functionalities.
Reductive amination of aldehydes or ketones with amines using sodium cyanoborohydride or borane derivatives.

Industrial Synthesis

Large‑scale production of C17H25NO5 compounds typically employs step‑economical pathways with high overall yields. Process optimization focuses on:

Minimizing the use of hazardous reagents by employing greener catalysts.
Utilizing solvent‑free or aqueous conditions where feasible.
Implementing continuous‑flow reactors to enhance safety for exothermic steps.
Applying microwave‑assisted synthesis to reduce reaction times.

Quality control is maintained through in‑process analytical techniques, ensuring consistent purity and structural integrity of the final product.

Analytical Identification

Mass Spectrometry

High‑resolution mass spectrometry (HRMS) provides accurate mass measurements that confirm the elemental composition. Tandem MS (MS/MS) yields fragmentation patterns revealing the locations of carbonyl and ester bonds, enabling differentiation between isomeric structures. Ionization methods include electrospray ionization (ESI) and matrix‑assisted laser desorption/ionization (MALDI).

Nuclear Magnetic Resonance

¹H and ¹³C NMR spectroscopy is essential for structural elucidation. Two‑dimensional techniques such as HSQC, HMBC, and COSY assist in mapping proton–carbon connectivity. NOESY or ROESY experiments elucidate spatial relationships, aiding in stereochemical assignments.

Infrared Spectroscopy

IR spectra serve as a rapid fingerprinting tool, with characteristic absorptions for carbonyl, hydroxyl, and ether groups. Comparative analysis with reference spectra can differentiate between ester, lactone, and amide linkages.

Chromatographic Techniques

High‑performance liquid chromatography (HPLC) separates isomers and assesses purity. Reverse‑phase columns using a gradient of water and acetonitrile with formic acid or trifluoroacetic acid as modifiers are common. Detection methods include UV absorption (λ = 254 nm) and evaporative light scattering detection (ELSD) for non‑chromophoric compounds.

Biological Activity

Pharmacological Targets

Compounds with the C17H25NO5 formula often act on protein targets such as:

β‑Adrenergic receptors, modulating cardiovascular function.
Serotonin transporters, influencing central nervous system activity.
Protein kinases, inhibiting phosphorylation pathways involved in cancer or inflammatory responses.
Acetylcholinesterase, leading to effects on cholinergic signaling.

The combination of aromatic rings and nitrogenous side chains facilitates interactions within the active sites of these proteins.

Pharmacokinetics

Key pharmacokinetic parameters include:

Absorption: Typically achieved through passive diffusion, aided by lipophilic character.
Distribution: Controlled by plasma protein binding, largely influenced by the presence of carboxylic acids or amides.
Metabolism: Predominantly mediated by hepatic esterases, cytochrome P450 enzymes, and conjugation pathways (glucuronidation).
Excretion: Occurs via renal filtration or biliary elimination, depending on the compound’s polarity and size.

Formulation strategies often incorporate salts (e.g., hydrochloride) or co‑solvents to improve bioavailability.

Structure‑Activity Relationships (SAR)

Systematic modifications of the ester or amide substituents, alteration of ring size, and stereochemical changes provide insights into the molecular determinants of activity. Computational docking and molecular dynamics simulations complement experimental SAR studies, predicting binding affinities and conformational preferences.

Regulatory Considerations

Safety and Toxicology

Regulatory agencies require comprehensive safety profiles for drugs bearing the C17H25NO5 formula. Toxicological assessments include:

Acute toxicity studies in rodent models, determining LD₅₀ values.
Sub‑chronic exposure studies assessing organ‑specific accumulation.
Genotoxicity assays (e.g., Ames test) to detect mutagenic potential.
Phototoxicity evaluations to rule out skin sensitization under UV exposure.

All safety data are compiled into Investigational New Drug (IND) applications or equivalent submissions.

Pharmacopoeial Standards

Standard monographs outline purity criteria, impurity limits, and analytical methods for drugs with this formula. Regulatory compliance involves:

Meeting established dissolution profiles for oral dosage forms.
Demonstrating consistent batch‑to‑batch variability within ± 2 % of the nominal potency.
Maintaining sterility and stability under specified storage conditions.

Adherence to Good Manufacturing Practice (GMP) ensures that the drug product meets all safety, efficacy, and quality benchmarks.

Conclusion

The molecular formula C17H25NO5 encompasses a broad spectrum of chemical entities, from complex pharmaceuticals and natural products to industrial intermediates. Their high degree of unsaturation, functional diversity, and potential for stereochemical complexity make them both challenging to synthesize and rewarding targets for medicinal chemistry. Ongoing advances in green chemistry, stereoselective synthesis, and analytical methods continue to expand the utility and safety of these compounds in both therapeutic and industrial contexts.

Search

Table of Contents